Key facts
- Tejara Capital Ltd filed SCHEDULE 13G for Cardiol Therapeutics Inc. Class A Common Shares (CRDL).
- Disclosed ownership: 5.2%.
- Date of event: 17 Oct 2025.
Tejara Capital Ltd - 17 Oct 2025 SCHEDULE 13G Report for Cardiol Therapeutics Inc. Class A Common Shares (CRDL)
- Filing Manager
- Tejara Capital Ltd
- Reporting Manager
- Tejara Capital Ltd
- Symbol
- CRDL
- Shares outstanding
- 98,656,192 shares
- Disclosed Ownership
- 5,130,122 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Oct 2025, 18:43:01 UTC
- Date of event
- 17 Oct 2025
- SEC
- View on sec.gov
Key filing fact
Tejara Capital Ltd disclosed 5.2% ownership in Cardiol Therapeutics Inc. Class A Common Shares (CRDL) on 17 Oct 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Oct 2025, 18:43.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Tejara Capital Ltd | 5.2% | 5,130,122 | 0 | 0 | Miyan Mansur Mannan | Director |
CIK / CUSIP context first